Schizophenia Disorder clinical trials at University of California Health
2 research studies open to eligible people
Showing trials for
Biomarkers to Enhance Early Schizophrenia Treatment
open to eligible people ages 18-35
This study is recruiting participants who are experiencing a first episode of psychosis and who have certain genetic factors that may make them respond better to certain medications that are used to treat people with psychosis.
at UCSD
Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)
open to eligible people ages 18-65
This randomized clinical trial will test a new technology-supported blended intervention, mobile Social Interaction Therapy by Exposure (mSITE), that targets social engagement in consumers with serious mental illness.
at UCSD
Our lead scientists for Schizophenia Disorder research studies include Eric Granholm, PhD.
Last updated: